Remibrutinib for treating chronic spontaneous urticaria inadequately controlled by H1-antihistamines in people 12 to 17 years [ID6649]

  • Awaiting development
  • GID-TA11861
  • Expected publication date: TBC

Documents

Documents created during the development process.

Notes